Defining the galaxy of gene expression in breast cancer - PubMed (original) (raw)
Editorial
Defining the galaxy of gene expression in breast cancer
Edison T Liu et al. Breast Cancer Res. 2002.
Abstract
Recent reports detailing the expression profiles of primary breast cancer have pointed to the utility of this approach in defining subclasses with distinct molecular configurations and clinical behaviour. Some of the subclasses can be predicted by current molecular tests: estrogen receptor status, p53 staining, and HER-2 overexpression. Others, however, are novel subgroups and may represent distinct cellular types. The results from two recent studies suggest common principles of classification by expression profiling. These principles are examined and the impact of these results on understanding the biology and the clinical behaviour of breast tumors is explored.
Similar articles
- Regulation of estrogen receptor expression.
Martin MB, Saceda M, Garcia-Morales P, Gottardis MM. Martin MB, et al. Breast Cancer Res Treat. 1994;31(2-3):183-9. doi: 10.1007/BF00666152. Breast Cancer Res Treat. 1994. PMID: 7881098 Review. No abstract available. - The regulation of estrogen receptor expression and function in human breast cancer.
Ferguson AT, Lapidus RG, Davidson NE. Ferguson AT, et al. Cancer Treat Res. 1998;94:255-78. doi: 10.1007/978-1-4615-6189-7_14. Cancer Treat Res. 1998. PMID: 9587692 Review. No abstract available. - Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H, Levesque MA, Clark GM, Diamandis EP. Yu H, et al. Br J Cancer. 1999 Oct;81(3):490-5. doi: 10.1038/sj.bjc.6690720. Br J Cancer. 1999. PMID: 10507775 Free PMC article. - Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
Pfeffer U, Fecarotta E, Arena G, Forlani A, Vidali G. Pfeffer U, et al. J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):99-105. doi: 10.1016/0960-0760(95)00227-8. J Steroid Biochem Mol Biol. 1996. PMID: 8603053 Review. - Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
Bièche I, Girault I, Urbain E, Tozlu S, Lidereau R. Bièche I, et al. Breast Cancer Res. 2004;6(3):R252-63. doi: 10.1186/bcr784. Epub 2004 Mar 26. Breast Cancer Res. 2004. PMID: 15084249 Free PMC article.
Cited by
- Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing.
Sun Z, Asmann YW, Kalari KR, Bot B, Eckel-Passow JE, Baker TR, Carr JM, Khrebtukova I, Luo S, Zhang L, Schroth GP, Perez EA, Thompson EA. Sun Z, et al. PLoS One. 2011 Feb 25;6(2):e17490. doi: 10.1371/journal.pone.0017490. PLoS One. 2011. PMID: 21364760 Free PMC article. - Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.
Abba MC, Lacunza E, Butti M, Aldaz CM. Abba MC, et al. Biomark Insights. 2010 Oct 27;5:103-18. doi: 10.4137/BMI.S5740. Biomark Insights. 2010. PMID: 21082037 Free PMC article. - Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A, Aldaz CM. Abba MC, et al. BMC Genomics. 2005 Mar 11;6:37. doi: 10.1186/1471-2164-6-37. BMC Genomics. 2005. PMID: 15762987 Free PMC article. - Breast cancer classification and prognosis based on gene expression profiles from a population-based study.
Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET. Sotiriou C, et al. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10393-8. doi: 10.1073/pnas.1732912100. Epub 2003 Aug 13. Proc Natl Acad Sci U S A. 2003. PMID: 12917485 Free PMC article.
References
- Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869–10874. - PMC - PubMed
- van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–535. doi: 10.1038/415530a. - DOI - PubMed
- Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. pp. 5979–5984. - PubMed
- Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med. 1995;1:1029–1034. - PubMed
- Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippman ME, King CR. Pathological findings from the National Surgical Adjuvant Bowel Project: prognostic significance of erbB2 protein in primary breast cancer. J Clin Oncol. 1990;8:103–112. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous